Atıf Formatları
Impact of proactive low-molecular weight heparin therapy on outcomes in COVID-19
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

S. GÖRMEZ Et Al. , "Impact of proactive low-molecular weight heparin therapy on outcomes in COVID-19," BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY , vol.122, no.8, pp.582-589, 2021

GÖRMEZ, S. Et Al. 2021. Impact of proactive low-molecular weight heparin therapy on outcomes in COVID-19. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY , vol.122, no.8 , 582-589.

GÖRMEZ, S., Gumusel, H. K., Ekicibasi, E., DEĞİRMENCİOĞLU, A., PAUDEL, A., Akan, G., ... Atalar, F.(2021). Impact of proactive low-molecular weight heparin therapy on outcomes in COVID-19. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY , vol.122, no.8, 582-589.

GÖRMEZ, SELÇUK Et Al. "Impact of proactive low-molecular weight heparin therapy on outcomes in COVID-19," BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY , vol.122, no.8, 582-589, 2021

GÖRMEZ, SELÇUK Et Al. "Impact of proactive low-molecular weight heparin therapy on outcomes in COVID-19." BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY , vol.122, no.8, pp.582-589, 2021

GÖRMEZ, S. Et Al. (2021) . "Impact of proactive low-molecular weight heparin therapy on outcomes in COVID-19." BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY , vol.122, no.8, pp.582-589.

@article{article, author={SELÇUK GÖRMEZ Et Al. }, title={Impact of proactive low-molecular weight heparin therapy on outcomes in COVID-19}, journal={BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY}, year=2021, pages={582-589} }